SMD.L Regulatory News (SMD)

Spectral MD Holdings, Ltd

("Spectral MD" or the "Company" or the Group")

Mediscience Award Win

Spectral MD win Best Technology award at the European Mediscience Awards

LONDON, U.K AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has won the Best Technology award at the European Mediscience Awards, held at Hotel InterContinental, London, last night.

The Best Technology award is awarded for a technology that is innovative, well funded, and capable of significant commercial success even if it is not yet proven. The technology concerned could have been developed within the organization or acquired. Spectral MD received the award for its DeepView® Wound Imaging System, a predictive analytics platform that combines AI algorithms and medical imaging for wound prediction.

The European Mediscience Awards is the largest annual gathering of private and publicly quoted healthcare, biotech and life sciences companies in Europe, bringing together the best European mediscience companies to celebrate achievement and recognise success.

Wensheng Fan, Chief Executive Officer of Spectral MD, commented: "I was delighted to collect this award last night on behalf of the Spectral MD team. This award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology that we continue to develop. We are honored to be recognized on an international stage at such a prestigious event."

For further information please contact:

About Spectral MD:

We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by "Seeing the Unknown" ® with our DeepView® Wound Imaging System.

www.spectralmd.com

info@spectralmd.com